| Sumit K Nanda, MD | |
|
3366 Nw Expressway, Ste 750, Oklahoma City, OK 73112 | |
| (405) 948-2020 | |
| (405) 948-2760 |
| Full Name | Sumit K Nanda |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 3366 Nw Expressway, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407840515 | NPI | - | NPPES |
| 100096150B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 18577 (Oklahoma) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 18577 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summit Medical Center | Edmond, OK | Hospital |
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Retina Consultants Pc | 4789746744 | 2 |
News Archive
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.
The Expert Breast Cancer Panel of the National Comprehensive Cancer Network (NCCN) met July 10-12, 2011 in Philadelphia, PA. At the meeting, the multidisciplinary breast cancer experts voted in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer on the use of bevacizumab in metastatic breast cancer.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
› Verified 7 days ago
| Entity Name | Oklahoma Retina Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093888356 PECOS PAC ID: 4789746744 Enrollment ID: O20081229000560 |
News Archive
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.
The Expert Breast Cancer Panel of the National Comprehensive Cancer Network (NCCN) met July 10-12, 2011 in Philadelphia, PA. At the meeting, the multidisciplinary breast cancer experts voted in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer on the use of bevacizumab in metastatic breast cancer.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sumit K Nanda, MD 3366 Nw Expressway, Ste 750, Oklahoma City, OK 73112 Ph: (405) 948-2020 | Sumit K Nanda, MD 3366 Nw Expressway, Ste 750, Oklahoma City, OK 73112 Ph: (405) 948-2020 |
News Archive
In a time when deficits have reduced states' budgets and the services they can provide, a new study shows that the Internet might offer communities a low-cost way to motivate their overweight residents to lose pounds.
Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science describes recent advances in sequencing technology.
Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.
The Expert Breast Cancer Panel of the National Comprehensive Cancer Network (NCCN) met July 10-12, 2011 in Philadelphia, PA. At the meeting, the multidisciplinary breast cancer experts voted in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer on the use of bevacizumab in metastatic breast cancer.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
› Verified 7 days ago
Vinay Ashok Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9821 S May Ave Ste C, Oklahoma City, OK 73159 Phone: 405-691-0505 Fax: 405-691-0507 | |
Cynthia A Bradford, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
Jila Noorikolouri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-3013 | |
Dr. Brian Keith Firestone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
David W Parke Ii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1092 | |
Gary Waine Wilson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7101 Nw Expressway, Suite 335, Oklahoma City, OK 73132 Phone: 405-722-2020 Fax: 405-516-6126 | |
David W. Jackson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1095 |